HealthQuill Epstein-Barr virus
Atara Biotherapeutics’ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug regulator.
Drugs Health Pharma

US drug regulator rejects Atara Biotherapeutics’ rare cancer therapy

Atara Biotherapeutics’ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug.

Read More
Health Medical Research

Study reveals early signs of Multiple Sclerosis in children

Bharti Jayshankar December 28, 2024: A recent research reveals that certain symptoms precede a diagnosis of multiple sclerosis (MS) in pediatric patients. The.

Read More
The jury is still out on which virus causes chronic fatigue syndrome, its diagnosis, the treatment options, and even its very terminology. Molecular biologists at the Cornell University revisited the syndrome, which is also known as myalgic encephalomyelitis (ME) and found it may be triggered by viral infections.
Drugs Health Pharma

Jury still out on chronic fatigue syndrome’s causes, treatment

HQ Team September 3, 2023: The jury is still out on which virus causes chronic fatigue syndrome, its diagnosis, the treatment options, and.

Read More
A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher risk of developing multiple sclerosis.
Drugs Health Pharma

Vaccine to treat Epstein-Brarr virus developed in mice

HQ Team August 17, 2023: A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher.

Read More